Browse by Changes
Summary of Changes – 1 April 2014
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Additions
- Deletions
- Alterations
- Advance Notices
- Section 100 – Highly Specialised Drugs Program
- Section 100 – Efficient Funding of Chemotherapy
Addition – Item
| 10075G | Calcipotriol + Betamethasone Dipropionate, betamethasone (as dipropionate) 0.05% + calcipotriol 0.005% gel, 60 g (Daivobet 50/500 gel) |
| 10080M | Clobetasol, clobetasol propionate 0.05% shampoo, 125 mL (Clobex) |
| 10061M | Denosumab, denosumab 120 mg/1.7 mL injection, 1 x 1.7 mL vial (Xgeva) |
| 10059K | Glycopyrronium, glycopyrronium 50 microgram inhalation, 30 capsules (seebri breezhaler) |
| 10063P | Homatropine, homatropine hydrobromide 2% eye drops, 15 mL (Isopto Homatropine) |
| 10076H | Nicotine, nicotine 25 mg/16 hours patch, 28 (nicorette 16hr Invisipatch) |
| 10062N | Temozolomide, temozolomide 180 mg capsule, 5 (Astromide, Orion Temozolomide, Temodal) |
| 10066T | Tobramycin, tobramycin 28 mg inhalation, 224 capsules (TOBI podhaler) |
| 10074F | Tobramycin, tobramycin 28 mg inhalation, 224 capsules (TOBI podhaler) |
Addition – Brand
| 2019G | Novatin, IA – Acitretin, acitretin 10 mg capsule, 100 |
| 2020H | Novatin, IA – Acitretin, acitretin 25 mg capsule, 100 |
| 9183H | Alendronate plus D3-DRLA, RZ – Alendronate + Colecalciferol, alendronate 70 mg + colecalciferol 140 microgram tablet, 4 |
| 2688L | APO-Azathioprine, TX – Azathioprine, azathioprine 25 mg tablet, 100 |
| 8384G | Optifresh eye gel, PP – Carbomer-980, carbomer-980 0.2% eye gel, 10 g |
| 5503P | Optifresh eye gel, PP – Carbomer-980, carbomer-980 0.2% eye gel, 10 g |
| 9210R | Optifresh eye gel, PP – Carbomer-980, carbomer-980 0.2% eye gel, 10 g |
| 2338C | Optifresh Tears, PP – Carmellose Sodium, carmellose sodium 0.5% (2 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 5506T | Optifresh Tears, PP – Carmellose Sodium, carmellose sodium 0.5% (2 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 2324H | Optifresh Plus, PP – Carmellose Sodium, carmellose sodium 1% (4 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 5505R | Optifresh Plus, PP – Carmellose Sodium, carmellose sodium 1% (4 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 5045M | APO-Cefaclor CD, TX – Cefaclor, cefaclor 375 mg tablet: modified release, 10 tablets |
| 1169M | APO-Cefaclor CD, TX – Cefaclor, cefaclor 375 mg tablet: modified release, 10 tablets |
| 1207M | APO-Metoclopramide, TX – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
| 1207M | Metoclopramide Actavis, GN – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
| 5151D | APO-Metoclopramide, TX – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
| 5151D | Metoclopramide Actavis, GN – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
| 1324Q | Metoprolol Actavis, GN – Metoprolol Tartrate, METOPROLOL TARTRATE Tablet 50 mg, 100 |
| 1325R | Metoprolol Actavis, GN – Metoprolol Tartrate, METOPROLOL TARTRATE Tablet 100 mg, 60 |
| 3496B | APO-Salbutamol, TX – Salbutamol, salbutamol 2.5 mg/2.5 mL inhalation: solution, 30 x 2.5 mL ampoules (Prescriber Bag) |
| 2000G | APO-Salbutamol, TX – Salbutamol, salbutamol 2.5 mg/2.5 mL inhalation: solution, 30 x 2.5 mL ampoules |
| 3497C | APO-Salbutamol, TX – Salbutamol, salbutamol 5 mg/2.5 mL inhalation: solution, 30 x 2.5 mL ampoules (Prescriber Bag) |
| 2001H | APO-Salbutamol, TX – Salbutamol, salbutamol 5 mg/2.5 mL inhalation: solution, 30 x 2.5 mL ampoules |
Addition – Equivalence Indicator
| 2019G | Neotigason, TA – Acitretin, acitretin 10 mg capsule, 100 |
| 2020H | Neotigason, TA – Acitretin, acitretin 25 mg capsule, 100 |
| 2338C | Cellufresh, AG – Carmellose Sodium, carmellose sodium 0.5% (2 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 5506T | Cellufresh, AG – Carmellose Sodium, carmellose sodium 0.5% (2 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 2324H | Celluvisc, AG – Carmellose Sodium, carmellose sodium 1% (4 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 5505R | Celluvisc, AG – Carmellose Sodium, carmellose sodium 1% (4 mg/0.4 mL) eye drops, 30 x 0.4 mL unit doses |
| 1207M | Maxolon, VT – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
| 5151D | Maxolon, VT – Metoclopramide, metoclopramide hydrochloride anhydrous 10 mg tablet, 25 |
Addition – Note
| 2715X | Doxycycline, doxycycline 100 mg capsule: modified release, 21 capsules (Doryx, Mayne Pharma Doxycycline) |
| 3322W | Doxycycline, doxycycline 100 mg capsule: modified release, 7 capsules (Doryx, Mayne Pharma Doxycycline) |
| 2708M | Doxycycline, doxycycline 100 mg capsule: modified release, 7 capsules (Doryx, Mayne Pharma Doxycycline) |
| 2703G | Doxycycline, doxycycline 100 mg capsule: modified release, 7 capsules (Doryx, Mayne Pharma Doxycycline) |
| 2707L | Doxycycline, doxycycline 50 mg capsule: modified release, 25 capsules (Doryx, Mayne Pharma Doxycycline) |
Deletion – Item
| 2742H | Flutamide, flutamide 250 mg tablet, 30 (Flutamide MYLAN) |
| 2332R | Morphine, morphine sulphate 10 mg/mL injection (with preservative), 10 x 1 mL ampoules (Morphine Sulphate Wockhardt) |
| 2333T | Morphine, morphine sulphate 10 mg/mL injection (with preservative), 10 x 1 mL ampoules (Morphine Sulphate Wockhardt) |
| 8681X | Oxycodone, oxycodone hydrochloride 5 mg tablet: modified release, 28 tablets (OxyContin) |
| 2391W | Simvastatin + Sitagliptin, simvastatin 10 mg + sitagliptin 100 mg tablet: film-coated, 28 (Juvicor) |
| 2377D | Simvastatin + Sitagliptin, simvastatin 20 mg + sitagliptin 100 mg tablet: film-coated, 28 (Juvicor) |
| 2383K | Simvastatin + Sitagliptin, simvastatin 40 mg + sitagliptin 100 mg tablet: film-coated, 28 (Juvicor) |
| 2745L | Tropisetron, tropisetron 5 mg capsule, 2 (Navoban) |
Deletion – Brand
| 1474N | Baxter Healthcare Pty Ltd, BX – Fluconazole, fluconazole 200 mg/100 mL injection, 1 x 100 mL vial |
| 1757L | Baxter Healthcare Pty Ltd, BX – Fluconazole, fluconazole 400 mg/200 mL injection, 1 x 200 mL bag |
| 3050M | GenRx Perindopril, GX – Perindopril, perindopril erbumine 2 mg tablet, 30 |
| 3051N | GenRx Perindopril, GX – Perindopril, perindopril erbumine 4 mg tablet, 30 |
| 8704D | GenRx Perindopril, GX – Perindopril, perindopril erbumine 8 mg tablet, 30 |
| 2746M | Navoban, NV – Tropisetron, tropisetron 5 mg/5 mL injection, 1 x 5 mL ampoule |
Deletion – Equivalence Indicator
| 1757L | Fluconazole Alphapharm, AF – Fluconazole, fluconazole 400 mg/200 mL injection, 1 x 200 mL bag |
| 2746M | Tropisetron-AFT, AE – Tropisetron, tropisetron 5 mg/5 mL injection, 1 x 5 mL ampoule |
Deletion – Note
| 10019H | Erlotinib, erlotinib 100 mg tablet, 30 (Tarceva) |
| 10020J | Erlotinib, erlotinib 100 mg tablet, 30 (Tarceva) |
| 9167L | Erlotinib, erlotinib 100 mg tablet, 30 (Tarceva) |
| 10014C | Erlotinib, erlotinib 150 mg tablet, 30 (Tarceva) |
| 10025P | Erlotinib, erlotinib 150 mg tablet, 30 (Tarceva) |
| 9168M | Erlotinib, erlotinib 150 mg tablet, 30 (Tarceva) |
| 10022L | Erlotinib, erlotinib 25 mg tablet, 30 (Tarceva) |
| 10028T | Erlotinib, erlotinib 25 mg tablet, 30 (Tarceva) |
| 9166K | Erlotinib, erlotinib 25 mg tablet, 30 (Tarceva) |
| 8769M | Gefitinib, gefitinib 250 mg tablet, 30 (Iressa) |
Alteration – Restriction
| 3387G | Linagliptin, linagliptin 5 mg tablet, 30 (Trajenta) |
| 2672P | Misoprostol, misoprostol 200 microgram tablet, 4 (GyMiso) |
| 8983T | Saxagliptin, saxagliptin 5 mg tablet, 28 (Onglyza) |
| 9182G | Sitagliptin, sitagliptin 100 mg tablet, 28 (Januvia) |
| 9180E | Sitagliptin, sitagliptin 25 mg tablet, 28 (Januvia) |
| 9181F | Sitagliptin, sitagliptin 50 mg tablet, 28 (Januvia) |
| 9451K | Sitagliptin + Metformin, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 (Janumet) |
| 9449H | Sitagliptin + Metformin, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 (Janumet) |
| 9450J | Sitagliptin + Metformin, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 (Janumet) |
| 3415R | Vildagliptin, vildagliptin 50 mg tablet, 60 (Galvus) |
| 5476F | Vildagliptin + Metformin, vildagliptin 50 mg + metformin hydrochloride 1 g tablet, 60 (Galvumet 50/1000) |
| 5474D | Vildagliptin + Metformin, vildagliptin 50 mg + metformin hydrochloride 500 mg tablet, 60 (Galvumet 50/500) |
| 5475E | Vildagliptin + Metformin, vildagliptin 50 mg + metformin hydrochloride 850 mg tablet, 60 (Galvumet 50/850) |
Alterations to the restrictions for the following items relating to juvenile idiopathic arthritis are outlined below:
- The addition of tocilizumab on the PBS for the treatment of this condition.
- The treatment break for adults has also been amended from 12 months to 24 months.
- For the adalimumab items, the Initial 3 restrictions (grandfather restrictions) have been removed for children as well as for adults.
| 5282B | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 5284D | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) |
| 5281Y | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 5283C | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) |
| 3445H | Etanercept, etanercept 25 mg injection [4 x 25 mg vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3448L | Etanercept, etanercept 25 mg injection [4 x 25 mg vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3447K | Etanercept, ETANERCEPT Injection 50 mg in 1 mL single use auto-injector, 4, 1 (Enbrel) |
| 3450N | Etanercept, ETANERCEPT Injection 50 mg in 1 mL single use auto-injector, 4, 1 (Enbrel) |
| 3446J | Etanercept, ETANERCEPT Injections 50 mg in 1 mL single use pre-filled syringes, 4, 1 (Enbrel) |
| 3449M | Etanercept, ETANERCEPT Injections 50 mg in 1 mL single use pre-filled syringes, 4, 1 (Enbrel) |
Alteration – Note
| 1800R | Doxycycline, doxycycline 100 mg tablet, 21 (GenRx Doxycycline) |
| 5082L | Doxycycline, doxycycline 100 mg tablet, 7 (Chem mart Doxycycline, Doxycycline Sandoz, Doxyhexal, GenRx Doxycycline, Terry White Chemists Doxycycline) |
| 9105F | Doxycycline, doxycycline 100 mg tablet, 7 (Chem mart Doxycycline, Doxycycline Sandoz, Doxyhexal, GenRx Doxycycline, Terry White Chemists Doxycycline) |
| 9108J | Doxycycline, doxycycline 100 mg tablet, 7 (Chem mart Doxycycline, Doxycycline Sandoz, Doxyhexal, Terry White Chemists Doxycycline) |
| 9107H | Doxycycline, doxycycline 100 mg tablet, 7 (Chem mart Doxycycline, Doxycycline Sandoz, Doxyhexal, GenRx Doxycycline, Terry White Chemists Doxycycline) |
| 3321T | Doxycycline, doxycycline 100 mg tablet, 7 (Doxsig, Doxy-100, Doxylin 100) |
| 2709N | Doxycycline, doxycycline 100 mg tablet, 7 (Doxsig, Doxy-100, Doxylin 100) |
| 2714W | Doxycycline, doxycycline 100 mg tablet, 7 (Doxsig, Doxy-100, Doxylin 100) |
| 2702F | Doxycycline, doxycycline 100 mg tablet, 7 (Doxsig, Doxy-100, Doxylin 100) |
| 2711Q | Doxycycline, doxycycline 50 mg tablet, 25 (Doxy-50, Doxylin 50) |
| 9106G | Doxycycline, doxycycline 50 mg tablet, 25 (Chem mart Doxycycline, Doxycycline Sandoz, Doxyhexal, Frakas, GenRx Doxycycline, Terry White Chemists Doxycycline) |
Alteration – Manufacturer's Code
| From | To | ||
|---|---|---|---|
| 1502C | Colifoam, HM – Hydrocortisone Acetate, hydrocortisone acetate 10% (100 mg/g) enema, 21.1 g |
AS |
HM |
| 8707G | Eligard 1 month, TL – Leuprorelin, leuprorelin acetate 7.5 mg injection: modified release [1 syringe] (&) inert substance diluent [1 syringe], 1 pack |
HH |
TL |
| 8708H | Eligard 3 month, TL – Leuprorelin, leuprorelin acetate 22.5 mg injection: modified release [1 syringe] (&) inert substance diluent [1 syringe], 1 pack |
HH |
TL |
| 8709J | Eligard 4 month, TL – Leuprorelin, leuprorelin acetate 30 mg injection: modified release [1 syringe] (&) inert substance diluent [1 syringe], 1 pack |
HH |
TL |
| 8859G | Eligard 6 month, TL – Leuprorelin, leuprorelin acetate 45 mg injection: modified release [1 syringe] (&) inert substance diluent [1 syringe], 1 pack |
HH |
TL |
Advance Notices – Deletion of Item
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 May 2014:
| 2041K | Carbomer + Triglyceride Lipids, carbomer 0.2% + triglyceride lipids 1% eye gel, 10 g (Artelac) |
| 2082N | Carbomer + Triglyceride Lipids, carbomer 0.2% + triglyceride lipids 1% eye gel, 10 g (Artelac) |
| 2044N | Carbomer + Triglyceride Lipids, carbomer 0.2% + triglyceride lipids 1% eye gel, 10 g (Artelac) |
| 2826R | Methysergide, methysergide 1 mg tablet, 50 (Deseril) |
| 1278G | Timolol, timolol 0.25% (2.5 mg/mL) eye drops, 5 mL (Tenopt) |
| 5547Y | Timolol, timolol 0.25% (2.5 mg/mL) eye drops, 5 mL (Tenopt) |
| 8723D | Glucose Indicator Blood, glucose indicator blood strip: diagnostic, 50 (Omnitest EZ) |
| 9265P | Glucose Indicator Blood, glucose indicator blood strip: diagnostic, 50 (Omnitest EZ) |
Advance Notices – Deletion of Brand
The following brands will be deleted from the Schedule of Pharmaceutical Benefits on 1 June 2014:
| 1453L | Lopid, PF – Gemfibrozil, gemfibrozil 600 mg tablet, 60 |
| 9248R | Lopid, PF – Gemfibrozil, gemfibrozil 600 mg tablet, 60 |
Section 100 – Highly Specialised Drugs Program
Addition – Item
| 10065R | Dolutegravir, dolutegravir 50 mg tablet, 30 (Tivicay) (Public) |
| 10070B | Dolutegravir, dolutegravir 50 mg tablet, 30 (Tivicay) (Private) |
| 10067W | Infliximab, infliximab 100 mg injection, 1 x 100 mg vial (Remicade) (Public) |
| 10057H | Infliximab, infliximab 100 mg injection, 1 x 100 mg vial (Remicade) (Private) |
| 10077J | Tocilizumab, tocilizumab 80 mg/4 mL injection, 1 x 4 mL vial (Actemra) (Public) |
| 10068X | Tocilizumab, tocilizumab 80 mg/4 mL injection, 1 x 4 mL vial (Actemra) (Private) |
| 10081N | Tocilizumab, tocilizumab 80 mg/4 mL injection, 1 x 4 mL vial (Actemra) (Public) |
| 10073E | Tocilizumab, tocilizumab 80 mg/4 mL injection, 1 x 4 mL vial (Actemra) (Private) |
| 10056G | Tocilizumab, tocilizumab 200 mg/10 mL injection, 1 x 10 mL vial (Actemra) (Public) |
| 10079L | Tocilizumab, tocilizumab 200 mg/10 mL injection, 1 x 10 mL vial (Actemra) (Private) |
| 10058J | Tocilizumab, tocilizumab 200 mg/10 mL injection, 1 x 10 mL vial (Actemra) (Public) |
| 10071C | Tocilizumab, tocilizumab 200 mg/10 mL injection, 1 x 10 mL vial (Actemra) (Private) |
| 10064Q | Tocilizumab, tocilizumab 400 mg/20 mL injection, 1 x 20 mL vial (Actemra) (Public) |
| 10060L | Tocilizumab, tocilizumab 400 mg/20 mL injection, 1 x 20 mL vial (Actemra) (Private) |
| 10072D | Tocilizumab, tocilizumab 400 mg/20 mL injection, 1 x 20 mL vial (Actemra) (Public) |
| 10078K | Tocilizumab, tocilizumab 400 mg/20 mL injection, 1 x 20 mL vial (Actemra) (Private) |
Addition – Equivalence Indicator
| 5705G | Caelyx, JC – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Public) |
| 6249X | Caelyx, JC – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Private) |
Alteration – Brand Name
| From: | |
| 6249X | Lipodox, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Private) |
| To: | |
| 6249X | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Private) |
| From: | |
| 5705G | Lipodox, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Public) |
| To: | |
| 5705G | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Public) |
Alteration – Restriction
The restrictions for the following items have been altered to remove the CD4+ cell count restriction for initiation of first line anti-retroviral therapy (ART) in asymptomatic, ART naïve HIV positive patients:
| 5602W | Abacavir, abacavir 20 mg/mL oral liquid, 240 mL (Ziagen) (Public) |
| 6265R | Abacavir, abacavir 20 mg/mL oral liquid, 240 mL (Ziagen) (Private) |
| 5601T | Abacavir, abacavir 300 mg tablet, 60 (Ziagen) (Public) |
| 6264Q | Abacavir, abacavir 300 mg tablet, 60 (Ziagen) (Private) |
| 5603X | Abacavir + Lamivudine, abacavir 600 mg + lamivudine 300 mg tablet, 30 (Kivexa) (Public) |
| 6458X | Abacavir + Lamivudine, abacavir 600 mg + lamivudine 300 mg tablet, 30 (Kivexa) (Private) |
| 5604Y | Abacavir + Lamivudine + Zidovudine, abacavir 300 mg + lamivudine 150 mg + zidovudine 300 mg tablet, 60 (Trizivir) (Public) |
| 6327B | Abacavir + Lamivudine + Zidovudine, abacavir 300 mg + lamivudine 150 mg + zidovudine 300 mg tablet, 60 (Trizivir) (Private) |
| 5615M | Atazanavir, atazanavir 100 mg capsule, 60 (Reyataz) (Public) |
| 9646Q | Atazanavir, atazanavir 100 mg capsule, 60 (Reyataz) (Private) |
| 5613K | Atazanavir, atazanavir 150 mg capsule, 60 (Reyataz) (Public) |
| 6451M | Atazanavir, atazanavir 150 mg capsule, 60 (Reyataz) (Private) |
| 5614L | Atazanavir, atazanavir 200 mg capsule, 60 (Reyataz) (Public) |
| 6452N | Atazanavir, atazanavir 200 mg capsule, 60 (Reyataz) (Private) |
| 5612J | Atazanavir, atazanavir 300 mg capsule, 30 (Reyataz) (Public) |
| 9614B | Atazanavir, atazanavir 300 mg capsule, 30 (Reyataz) (Private) |
| 5663C | Didanosine, didanosine 125 mg capsule: enteric, 30 (Videx EC) (Public) |
| 6298L | Didanosine, didanosine 125 mg capsule: enteric, 30 (Videx EC) (Private) |
| 5664D | Didanosine, didanosine 200 mg capsule: enteric, 30 (Videx EC) (Public) |
| 6299M | Didanosine, didanosine 200 mg capsule: enteric, 30 (Videx EC) (Private) |
| 5665E | Didanosine, didanosine 250 mg capsule: enteric, 30 (Videx EC) (Public) |
| 6300N | Didanosine, didanosine 250 mg capsule: enteric, 30 (Videx EC) (Private) |
| 5666F | Didanosine, didanosine 400 mg capsule: enteric, 30 (Videx EC) (Public) |
| 6301P | Didanosine, didanosine 400 mg capsule: enteric, 30 (Videx EC) (Private) |
| 5708K | Efavirenz, efavirenz 200 mg tablet, 90 (Stocrin) (Public) |
| 9618F | Efavirenz, efavirenz 200 mg tablet, 90 (Stocrin) (Private) |
| 5707J | Efavirenz, efavirenz 30 mg/mL oral liquid, 180 mL (Stocrin) (Public) |
| 6372J | Efavirenz, efavirenz 30 mg/mL oral liquid, 180 mL (Stocrin) (Private) |
| 5706H | Efavirenz, efavirenz 600 mg tablet, 30 (Stocrin) (Public) |
| 6356M | Efavirenz, efavirenz 600 mg tablet, 30 (Stocrin) (Private) |
| 5709L | Emtricitabine, emtricitabine 200 mg capsule, 30 (Emtriva) (Public) |
| 6137B | Emtricitabine, emtricitabine 200 mg capsule, 30 (Emtriva) (Private) |
| 1491L | Emtricitabine + Rilpivirine + Tenofovir, emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet, 30 (Eviplera) (Public) |
| 1490K | Emtricitabine + Rilpivirine + Tenofovir, emtricitabine 200 mg + rilpivirine 25 mg + tenofovir disoproxil fumarate 300 mg tablet, 30 (Eviplera) (Private) |
| 5745J | Fosamprenavir, fosamprenavir 50 mg/mL oral liquid, 225 mL (Telzir) (Public) |
| 6454Q | Fosamprenavir, fosamprenavir 50 mg/mL oral liquid, 225 mL (Telzir) (Private) |
| 5746K | Fosamprenavir, fosamprenavir 700 mg tablet, 60 (Telzir) (Public) |
| 6453P | Fosamprenavir, fosamprenavir 700 mg tablet, 60 (Telzir) (Private) |
| 5752R | Indinavir, indinavir 400 mg capsule, 180 (Crixivan 400 mg) (Public) |
| 6202K | Indinavir, indinavir 400 mg capsule, 180 (Crixivan 400 mg) (Private) |
| 5773W | Lamivudine, lamivudine 10 mg/mL oral liquid, 240 mL (3TC) (Public) |
| 6194B | Lamivudine, lamivudine 10 mg/mL oral liquid, 240 mL (3TC) (Private) |
| 5772T | Lamivudine, lamivudine 150 mg tablet, 60 (3TC, Lamivudine Alphapharm, Lamivudine RBX) (Public) |
| 6193Y | Lamivudine, lamivudine 150 mg tablet, 60 (3TC, Lamivudine Alphapharm, Lamivudine RBX) (Private) |
| 5774X | Lamivudine, lamivudine 300 mg tablet, 30 (3TC, Lamivudine Alphapharm, Lamivudine RBX) (Public) |
| 6435Q | Lamivudine, lamivudine 300 mg tablet, 30 (3TC, Lamivudine Alphapharm, Lamivudine RBX) (Private) |
| 5775Y | Lamivudine + Zidovudine, lamivudine 150 mg + zidovudine 300 mg tablet, 60 (Combivir, Lamivudine 150 mg + Zidovudine 300 mg Alphapharm) (Public) |
| 6234D | Lamivudine + Zidovudine, lamivudine 150 mg + zidovudine 300 mg tablet, 60 (Combivir, Lamivudine 150 mg + Zidovudine 300 mg Alphapharm) (Private) |
| 5790R | Lopinavir + Ritonavir, lopinavir 100 mg + ritonavir 25 mg tablet, 60 (Kaletra) (Public) |
| 9633B | Lopinavir + Ritonavir, lopinavir 100 mg + ritonavir 25 mg tablet, 60 (Kaletra) (Private) |
| 5791T | Lopinavir + Ritonavir, lopinavir 200 mg + ritonavir 50 mg tablet, 120 (Kaletra) (Public) |
| 6495W | Lopinavir + Ritonavir, lopinavir 200 mg + ritonavir 50 mg tablet, 120 (Kaletra) (Private) |
| 5789Q | Lopinavir + Ritonavir, lopinavir 400 mg/5 mL + ritonavir 100 mg/5 mL oral liquid, 60 mL (Kaletra) (Public) |
| 6341R | Lopinavir + Ritonavir, lopinavir 400 mg/5 mL + ritonavir 100 mg/5 mL oral liquid, 60 mL (Kaletra) (Private) |
| 9507J | Nevirapine, nevirapine 10 mg/mL oral liquid, 240 mL (Viramune) (Public) |
| 9571R | Nevirapine, nevirapine 10 mg/mL oral liquid, 240 mL (Viramune) (Private) |
| 9506H | Nevirapine, nevirapine 200 mg tablet, 60 (Nevipin, Nevirapine Alphapharm, Nevirapine RBX, Viramune) (Public) |
| 6215D | Nevirapine, nevirapine 200 mg tablet, 60 (Nevipin, Nevirapine Alphapharm, Nevirapine RBX, Viramune) (Private) |
| 1132N | Nevirapine, nevirapine 400 mg tablet: modified release, 30 tablets (Viramune XR) (Public) |
| 1129K | Nevirapine, nevirapine 400 mg tablet: modified release, 30 tablets (Viramune XR) (Private) |
| 9523F | Raltegravir, raltegravir 400 mg tablet, 60 (Isentress) (Public) |
| 9629T | Raltegravir, raltegravir 400 mg tablet, 60 (Isentress) (Private) |
| 1173R | Rilpivirine, rilpivirine 25 mg tablet, 30 (Edurant) (Public) |
| 1170N | Rilpivirine, rilpivirine 25 mg tablet, 30 (Edurant) (Private) |
| 9660K | Ritonavir, ritonavir 100 mg tablet, 30 (Norvir) (Public) |
| 9677H | Ritonavir, ritonavir 100 mg tablet, 30 (Norvir) (Private) |
| 9542F | Ritonavir, ritonavir 600 mg/7.5 mL oral liquid, 90 mL (Norvir) (Public) |
| 6494T | Ritonavir, ritonavir 600 mg/7.5 mL oral liquid, 90 mL (Norvir) (Private) |
| 9545J | Saquinavir, saquinavir 500 mg tablet, 120 (Invirase) (Public) |
| 6498B | Saquinavir, saquinavir 500 mg tablet, 120 (Invirase) (Private) |
| 9553T | Stavudine, stavudine 20 mg capsule, 60 (Zerit) (Public) |
| 6186N | Stavudine, stavudine 20 mg capsule, 60 (Zerit) (Private) |
| 9554W | Stavudine, stavudine 30 mg capsule, 60 (Zerit) (Public) |
| 6189R | Stavudine, stavudine 30 mg capsule, 60 (Zerit) (Private) |
| 9556Y | Stavudine, stavudine 40 mg capsule, 60 (Zerit) (Public) |
| 6190T | Stavudine, stavudine 40 mg capsule, 60 (Zerit) (Private) |
| 9563H | Tenofovir, tenofovir disoproxil fumarate 300 mg tablet, 30 (Viread) (Public) |
| 6358P | Tenofovir, tenofovir disoproxil fumarate 300 mg tablet, 30 (Viread) (Private) |
| 9564J | Tenofovir + Emtricitabine, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Truvada) (Public) |
| 6468K | Tenofovir + Emtricitabine, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 (Truvada) (Private) |
| 9565K | Tenofovir + Emtricitabine + Efavirenz, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 (Atripla) (Public) |
| 9650X | Tenofovir + Emtricitabine + Efavirenz, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 (Atripla) (Private) |
| 9651Y | Zidovudine, zidovudine 100 mg capsule, 100 (Retrovir) (Public) |
| 6153W | Zidovudine, zidovudine 100 mg capsule, 100 (Retrovir) (Private) |
| 9652B | Zidovudine, zidovudine 250 mg capsule, 40 (Retrovir) (Public) |
| 6154X | Zidovudine, zidovudine 250 mg capsule, 40 (Retrovir) (Private) |
| 9570Q | Zidovudine, zidovudine 50 mg/5 mL oral liquid, 200 mL (Retrovir) (Public) |
| 6155Y | Zidovudine, zidovudine 50 mg/5 mL oral liquid, 200 mL (Retrovir) (Private) |
Alterations to the restrictions for the following items relating to juvenile idiopathic arthritis are outlined below:
- The addition of tocilizumab on the PBS for the treatment of this condition.
- The treatment break for adults has also been amended from 12 months to 24 months.
- For the adalimumab items, the Initial 3 restrictions (grandfather restrictions) have been removed for children as well as for adults.
| 9661L | Adalimumab, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Humira) (Public) |
| 9678J | Adalimumab, adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes (Humira) (Private) |
| 9663N | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) (Public) |
| 9680L | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira) (Private) |
| 9662M | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) (Public) |
| 9679K | Adalimumab, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira) (Private) |
| 5734T | Etanercept, etanercept 25 mg injection [4 x 25 mg vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) (Public) |
| 6367D | Etanercept, etanercept 25 mg injection [4 x 25 mg vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) (Private) |
| 5735W | Etanercept, ETANERCEPT Injection 50 mg in 1 mL single use auto-injector, 4, 1 (Enbrel) (Public) |
| 9641K | Etanercept, ETANERCEPT Injection 50 mg in 1 mL single use auto-injector, 4, 1 (Enbrel) (Private) |
| 5733R | Etanercept, ETANERCEPT Injections 50 mg in 1 mL single use pre-filled syringes, 4, 1 (Enbrel) (Public) |
| 9615C |
Etanercept, ETANERCEPT Injections 50 mg in 1 mL single use pre-filled syringes, 4, 1 (Enbrel) (Private) |
Section 100 – Efficient Funding of Chemotherapy
Addition – Item
| 10069Y | Panitumumab, panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix) |
| 10082P | Panitumumab, panitumumab 100 mg/5 mL injection, 1 x 5 mL vial (Vectibix) |
Deletion – Item
| 4360L | Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx) |
| 7228K | Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial (Caelyx) |
| 5986C | Tropisetron, tropisetron 5 mg capsule, 2 (Navoban) |
Deletion – Brand
| 5987D | Navoban, NV – Tropisetron, tropisetron 5 mg/5 mL injection, 1 x 5 mL ampoule |
Deletion – Note
| 4542C | Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial |
| Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | |
| Oxaliplatin, oxaliplatin 50 mg/10 mL injection, 1 x 10 mL vial | |
| Oxaliplatin, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial | |
| Oxaliplatin, oxaliplatin 200 mg/40 mL injection, 1 x 40 mL vial | |
| 7253R | Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial |
| Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | |
| Oxaliplatin, oxaliplatin 50 mg/10 mL injection, 1 x 10 mL vial | |
| Oxaliplatin, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial | |
| Oxaliplatin, oxaliplatin 200 mg/40 mL injection, 1 x 40 mL vial |
Alteration – Brand Name
| From: | |
| 7230M | Lipodox, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial |
| To: | |
| 7230M | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial |
| From: | |
| 4364Q | Lipodox, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial |
| To: | |
| 4364Q | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 20 mg/10 mL injection, 1 x 10 mL vial |
| From: | |
| 7230M | Lipodox 50, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial |
| To: | |
| 7230M | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial |
| From: | |
| 4364Q | Lipodox 50, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial |
| To: | |
| 4364Q | Liposomal Doxorubicin SUN, ZF – Doxorubicin Hydrochloride-pegylated Liposomal, doxorubicin hydrochloride-pegylated liposomal 50 mg/25 mL injection, 1 x 25 mL vial |
Alteration – Restriction
| 7273T | Cetuximab, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial, (Erbitux) |
| Cetuximab, cetuximab 500 mg/100 mL injection, 1 x 100 mL vial, (Erbitux) | |
| 4731B | Cetuximab, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial, (Erbitux) |
| Cetuximab, cetuximab 500 mg/100 mL injection, 1 x 100 mL vial, (Erbitux) | |
| 7242E | Cetuximab, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial, (Erbitux) |
| Cetuximab, cetuximab 500 mg/100 mL injection, 1 x 100 mL vial, (Erbitux) | |
| 4436L | Cetuximab, cetuximab 100 mg/20 mL injection, 1 x 20 mL vial, (Erbitux) |
| Cetuximab, cetuximab 500 mg/100 mL injection, 1 x 100 mL vial, (Erbitux) |
Alteration – Authority required (STREAMLINED) to Unrestricted
| 7249M | Irinotecan, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 1 x 2 mL vial |
| Irinotecan, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial | |
| Irinotecan, irinotecan hydrochloride trihydrate 300 mg/15 mL injection, 1 x 15 mL vial | |
| Irinotecan, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 1 x 25 mL vial | |
| 4451G | Irinotecan, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 1 x 2 mL vial |
| Irinotecan, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 1 x 5 mL vial | |
| Irinotecan, irinotecan hydrochloride trihydrate 300 mg/15 mL injection, 1 x 15 mL vial | |
| Irinotecan, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 1 x 25 mL vial | |
| 4542C | Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial |
| Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | |
| Oxaliplatin, oxaliplatin 50 mg/10 mL injection, 1 x 10 mL vial | |
| Oxaliplatin, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial | |
| Oxaliplatin, oxaliplatin 200 mg/40 mL injection, 1 x 40 mL vial | |
| 7253R | Oxaliplatin, oxaliplatin 50 mg injection, 1 x 50 mg vial |
| Oxaliplatin, oxaliplatin 100 mg injection, 1 x 100 mg vial | |
| Oxaliplatin, oxaliplatin 50 mg/10 mL injection, 1 x 10 mL vial | |
| Oxaliplatin, oxaliplatin 100 mg/20 mL injection, 1 x 20 mL vial | |
| Oxaliplatin, oxaliplatin 200 mg/40 mL injection, 1 x 40 mL vial |
Advance Notices – Deletion of Brand
The following items will be deleted from the Schedule of Pharmaceutical Benefits on 1 May 2014:
| 5581R | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 7281F | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 5582T | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 7282G | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 5583W | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 7283H | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 5584X | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 7284J | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 5585Y | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |
| 7285K | AS-Docetaxel, AF – Docetaxel, docetaxel 80 mg/2 mL injection, vial [1 x 2 mL vial] (&) inert substance diluent [1 vial], 1 pack |